| Financial Year |
March 31 2022 |
| Monetary Funds |
214,973,237.27 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
14,250,000.00 |
| Accounts Receivable |
102,384,812.63 |
| Advances to Suppliers |
22,116,972.19 |
| Other Receivables |
59,808,345.78 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
51,981,166.55 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,894,879.15 |
| Total Current Assets |
470,520,922.59 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
674,606.46 |
| Investment Properties |
156,344,700.00 |
| Fixed Assetes |
81,765,250.64 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
12,724,014.26 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,596,256.97 |
| Deferred Income Tax Assets |
3,273,598.21 |
| Other Non-Current Assets |
2,821,700.00 |
| Sub-Total of Non-Current Assets |
309,699,226.54 |
| Total Assets |
780,220,149.13 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
41,324,499.56 |
| Accounts Received In Advance |
3,374,340.95 |
| Employee Compensation Payable |
13,254,615.90 |
| Taxes Payable |
3,130,258.08 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
29,139,265.18 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
14,371,129.04 |
| Sub-Total of Current Liabilities |
106,415,928.06 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
531,215,072.56 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
531,969,378.29 |
| Total Liabilities |
638,385,306.35 |
| Paid-In Capital(Or Share Stock) |
556,920,000.00 |
| Capital Surplus |
799,956,473.16 |
| Surplus Reserve |
19,279,976.11 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,238,295,325.25 |
| Minority Stockholder's Interest |
2,314,708.64 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
139,520,134.14 |
| Owner's Equity（Stockholder's Equity） |
141,834,842.78 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
780,220,149.13 |
